Galway, Ireland

Neuravi Limited


USPTO Granted Patents = 131

% Expired Patents = 0.76


Trademarks = 1

Forward Citations = 2,179

Loading Chart...
Loading Chart...

53 inventors (with patents filed for the assignee):

goldMedal David Vale (92 out of 140 patents)

silverMedal Brendan Casey (75 out of 84 patents)

bronzeMedal Michael Gilvarry (63 out of 73 patents)

4.  Eamon Brady (49 out of 121 patents)

5.  Mahmood K Razavi (34 out of 39 patents)

6.  David Hardiman (23 out of 23 patents)

7.  Kevin McArdle (21 out of 21 patents)

8.  Ronald John Kelly (17 out of 38 patents)

9.  Karl Keating (16 out of 26 patents)

10.  Maeve Holian (15 out of 15 patents)

11.  Patrick Griffin (15 out of 62 patents)

12.  Jason McNamara (11 out of 11 patents)

13.  Jacqueline O'Gorman (10 out of 19 patents)

14.  Daniel King (10 out of 10 patents)

15.  Aidan Duffy (8 out of 16 patents)


Core Competencies:
Clot Retrieval Device
Thrombectomy System
Aspiration Catheter
Mechanical Thrombectomy
Intravascular Device
Balloon Catheter
Aspiration Control Valve
Floating Clot Retrieval
Vascular Obstruction
Self-Expanding Device
Cyclic Aspiration
Clot Engagement

131 patents:

Neuravi Limited, based in Galway, Ireland, specializes in the development of advanced clot retrieval devices aimed at improving patient outcomes in neurovascular interventions. The company focuses on innovative technologies such as thrombectomy systems, aspiration catheters, and mechanical thrombectomy solutions. Their products are designed to enhance the efficiency and effectiveness of clot removal procedures, addressing critical needs in the treatment of stroke and other vascular conditions, thereby contributing to the evolving landscape of medical devices in the field.
Profile summary based on public USPTO records.

logo

Company Badge

USPTO Data Jan 1 1976 - Sep 29 2026

Neuravi Limited
131 Patents

#3 in Galway

#23 in Ireland

#6,130 in the World

Galway, IE
Galway, Ireland
Forward Citations = 2,179

53 inventors:

Please report any incorrect information to [email protected]
Loading…